Michelle is Tanvex CDMO’s Senior Scientist specializing in upstream process development, with experience spanning the entire process from cell line selection to drug substance manufacturing. She has contributed to projects at every stage of development, applying her knowledge to define, optimize, and scale robust cell culture and fermentation processes. Driven by a passion for advancing life-saving therapies, Michelle has successfully collaborated on multiple biologic and biosimilar programs, playing a critical role in Tanvex’s mission to deliver innovative and impactful medicines.